• Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Hungary The Netherlands Poland Spain

  • Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia Denmark Estonia +11

  • Study on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

  • Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Czechia France Germany Hungary Ireland +5

  • Study on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Drugs:
    Bulgaria Czechia Denmark Estonia France Germany +12

  • Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany Greece Italy The Netherlands +2

  • Study on the Safety and Effects of Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    France Spain

  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Finland France Germany Greece Italy +3

  • Study on the Safety and Efficacy of PF-06835375 and Diphenhydramine Hydrochloride for Adults with Moderate to Severe Primary Immune Thrombocytopenia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Hungary Poland

  • Study on the Effects of Amlodipine and Irbesartan in Patients with High Blood Pressure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Greece

powered by